PRE-SOLICITATION NOTICE
ID: NOI-NIAID-25-2248410
Post Date: November 26, 2024
Response Date: December 6, 2024
NAICS: 541380
This is a Notice of Intent, NOT a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with the University of Washington for this requirement to perform qRT-PCR Testing Analysis on approximately 2,800 blood samples for the Malaria Infection Biology and Immunity Uni’s L9LS monoclonal antibody clinical trail conducted in Mali. The University of Washington laboratory will perform the only qRT-PCR assay for the detection and quantification of Plasmodium parasites that has received the Drug Development Tool Biomarker Qualification through the FDA.
Description of need:
Period of Performance: 1/01/2024-12/31/2025
Place of Performance
Rockville, MD 20852
The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement. All required documents must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov by December 6, 2024 10:00 am. All vendors must register in the eSASS system to submit their documentation. Instructions on how to register /submit documents are included on the website. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
